Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus

Experiments were conducted to examine the hypothesis that increased neuronal discharge activity of noradrenergic neurons of the locus coeruleus (LC) above resting discharge rates can alter forebrain electroencephalographic (EEG) activity. Small infusions (70-135 nl) of the cholinergic agonist bethanechol within 500 microns of the LC were used to activate this nucleus reversibly in halothane-anesthetized rats. A combined recording-infusion probe allowed verification of this electrophysiological activation. Simultaneously, EEG activity was recorded from sites in the frontal cortex and hippocampus and subjected to power-spectrum analyses. The findings were (1) LC activation was consistently followed, within 5 to 30 sec, by a shift from low- frequency, high-amplitude to high-frequency, low-amplitude EEG activity in frontal neocortex and by the appearance of intense theta-rhythm in the hippocampus; (2) forebrain EEG changes followed LC activation with similar latencies whether infusions were made lateral or medial to the LC; (3) infusions placed outside the immediate vicinity of the LC were not followed by these forebrain EEG effects; (4) following infusion- induced activation, forebrain EEG returned to preinfusion patterns with about the same time course as the recovery of LC activity (10-20 min for complete recovery). These infusion-induced effects on EEG activity were blocked or severely attenuated by pretreatment with the alpha 2- agonist clonidine, which inhibits LC discharge and norepinephrine release, or the beta-antagonist propranolol. These observations indicate that enhanced LC discharge activity is the crucial mediating event for the infusion-induced changes in forebrain EEG activity observed under these conditions and suggest that LC activation may be sufficient to induce EEG signs of cortical and hippocampal activation.

[1]  S. Foote,et al.  Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus , 1983, Brain Research.

[2]  C. H. Vanderwolf.  Cerebral activity and behavior: control by central cholinergic and serotonergic systems. , 1988, International review of neurobiology.

[3]  B. Bunney,et al.  Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine , 1975, Brain Research.

[4]  Terry E. Robinson,et al.  Reticulo-cortical activity and behavior: A critique of the arousal theory and a new synthesis , 1981, Behavioral and Brain Sciences.

[5]  J. Mäkelä,et al.  Effect of alpha-adrenoceptor blockade on sleep and wakefulness in the rat , 1986, Pharmacology Biochemistry and Behavior.

[6]  A. Waterman,et al.  Analgesic effects of intrathecally-applied α 2-adrenoceptor agonists in conscious, unrestrained sheep , 1988, Neuropharmacology.

[7]  M. Steriade,et al.  Brainstem Control of Wakefulness and Sleep , 1990, Springer US.

[8]  G. Buzsáki,et al.  Nucleus basalis and thalamic control of neocortical activity in the freely moving rat , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  J. Gnadt,et al.  Cholinergic brainstem mechanisms of REM sleep in the rat , 1986, Brain Research.

[10]  R. Nicoll,et al.  Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. , 1990, Physiological reviews.

[11]  J A Hobson,et al.  Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. , 1975, Science.

[12]  M. Jouvet,et al.  Mapping of cholinoceptive brainstem structures responsible for the generation of paradoxical sleep in the cat. , 1989, Archives italiennes de biologie.

[13]  V. Libri,et al.  Microinfusion of clonidine and yohimbine into locus coeruleus alters EEG power spectrum: effects of aging and reversal by phosphatidylserine , 1988, British journal of pharmacology.

[14]  V. Libri,et al.  Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms. , 1987, British journal of pharmacology.

[15]  Robert W. McCarley,et al.  A neuroanatomical gradient in the pontine tegmentum for the cholinoceptive induction of desynchronized sleep signs , 1987, Brain Research.

[16]  M. Jouvet,et al.  The effect of lesions of catecholamine-containing neurons upon monoamine content of the brain and EEG and behavioral waking in the cat. , 1973, Brain research.

[17]  B. C. Bloor,et al.  Reduction in Halothane Anesthetic Requirement by Clonidine, an Alpha‐Adrenergic Agonist , 1982, Anesthesia and analgesia.

[18]  S. T. Mason,et al.  Modulation of rat brain α- and β-adrenergic receptor populations by lesions of the dorsal noradrenergic bundle , 1980, Brain Research.

[19]  G Oakson,et al.  Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  R. Bandler,et al.  Flight and immobility evoked by excitatory amino acid microinjection within distinct parts of the subtentorial midbrain periaqueductal gray of the cat , 1990, Brain Research.

[21]  A. Abdel‐Rahman,et al.  Selective sensitization by L-glutamate of baroreflex-mediated bradycardia following microinjection into the rostral ventrolateral medulla. , 1990, Brain research.

[22]  S. T. Mason,et al.  Modulation of rat brain alpha- and beta-adrenergic receptor populations by lesion of the dorsal noradrenergic bundle. , 1980, Brain research.

[23]  J. A. Hobson,et al.  Evolving concepts of sleep cycle generation: From brain centers to neuronal populations , 1986, Behavioral and Brain Sciences.

[24]  R. North,et al.  Acetylcholine acts on m2‐muscarinic receptors to excite rat locus coeruleus neurones , 1985, British journal of pharmacology.

[25]  J. Monti,et al.  Effects of methoxamine and alpha-adrenoceptor antagonists, prazosin and yohimbine, on the sleep-wake cycle of the rat. , 1984, Sleep.

[26]  K. Fuxe,et al.  Effects of intracerebral injections of 6‐hydroxydopamine on sleep and waking in the rat , 1973, The Journal of pharmacy and pharmacology.

[27]  T. Itil,et al.  Central mechanisms of clonidine and propranolol in man. Quantitative Pharmaco-EEG with antihypertensive compounds. , 1983, Chest.

[28]  M. Jouvet,et al.  Inhibition of carbachol microinjections of presumptive cholinergic PGO-on neurons in freely moving cats , 1990, Brain Research.

[29]  David A. McCormick,et al.  Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarization-activated cation current , 1989, Nature.

[30]  F. Bloom,et al.  Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Warsh,et al.  Brain noradrenergic neuronal activity affects 3,4-dihydroxyphenylethyleneglycol (DHPG) levels. , 1981, Life sciences.

[32]  P. Lidbrink,et al.  The effect of lesions of ascending noradrenaline pathways on sleep and waking in the rat. , 1974, Brain research.

[33]  K. Taylor,et al.  Behavioural and biochemical effects of 2‐(2,6‐dichlorophenylamino)‐2‐imidazoline hydrochloride (St 155) on the central nervous system , 1969, British journal of pharmacology.

[34]  V. Libri,et al.  Evidence that locus coeruleus is the site where clonidine and drugs acting at α1‐ and α2‐adrenoceptors affect sleep and arousal mechanisms , 1987 .

[35]  D. Reis,et al.  Anatomical substrates of cholinergic‐autonomic regulation in the rat , 1990, The Journal of comparative neurology.

[36]  G. Buzsáki,et al.  Cellular bases of hippocampal EEG in the behaving rat , 1983, Brain Research Reviews.

[37]  A. Abdel‐Rahman,et al.  Selective sensitization byl-glutamate of baroreflex-mediated bradycardia following microinjection into the rostral ventrolateral medulla , 1990, Brain Research.

[38]  V. Libri,et al.  Effects of pertussis toxin on the behavioural and ECoG spectrum changes induced by clonidine and yohimbine after their microinfusion into the locus coeruleus , 1989, British journal of pharmacology.

[39]  Barbara E. Jones,et al.  Effects of locus coeruleus lesions upon cerebral monoamine content, sleep-wakefulness states and the response to amphetamine in the cat , 1977, Brain Research.

[40]  M. Jouvet,et al.  The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. , 1972, Ergebnisse der Physiologie, biologischen Chemie und experimentellen Pharmakologie.

[41]  F. Bloom,et al.  Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. , 1983, Physiological reviews.

[42]  W R Schmidek,et al.  Phases and states of sleep in the rat. , 1970, Physiology & behavior.

[43]  D. McCormick,et al.  Noradrenergic and serotonergic modulation of a hyperpolarization‐activated cation current in thalamic relay neurones. , 1990, The Journal of physiology.

[44]  S. Foote,et al.  Effects of locally infused pharmacological agents on spontaneous and sensory-evoked activity of locus coeruleus neurons , 1988, Brain Research Bulletin.

[45]  R. Gillis,et al.  Central nervous system site of action for the hypotensive effect of clonidine in the cat. , 1988, The Journal of pharmacology and experimental therapeutics.

[46]  J. Hobson,et al.  The carbachol-induced enhancement of desynchronized sleep signs is dose dependent and antagonized by centrally administered atropine. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[47]  D. Segal,et al.  Behavioral activation of rats during intraventricular infusion of norepinephrine. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Horst Kleinlogel.  Effects of the selective alpha 1-adrenoceptor blocker prazosin on EEG sleep and waking stages in the rat. , 1989, Neuropsychobiology.

[49]  M. Geyer,et al.  Behavior during hippocampal microinfusions. I. Norepinephrine and diversive exploration , 1982, Brain Research Reviews.